The EPA is now in charge of regulating the use of Oxitec’s strain of Aedes aegypti, genetically engineered to reduce populations of the insects.
August 8, 2000
NEW YORK, August 7 (Praxis Press) Dyspepsia encompasses a range of pathologies, and the most cost-effective approach for assessing and managing this symptom is debated. Lassen and colleagues compared the safety and efficacy of a Helicobacter pylori test-and-eradicate strategy with a prompt endoscopy strategy in 500 patients presenting with dyspepsia. One year after treatment, there were no differences between the two groups in the frequency of gastrointestinal symptoms, quality of life, number o